loadpatents
name:-0.0042779445648193
name:-0.017292976379395
name:-0.0005030632019043
Malcolm, Andrew J. Patent Filings

Malcolm, Andrew J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Malcolm, Andrew J..The latest application filed is for "immunoassay kit for measuring cyclosporine, its metabolites and derivatives".

Company Profile
0.9.3
  • Malcolm, Andrew J. - Edmonton CA
  • Malcolm; Andrew J. - Alberta CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Immunoassay kit for measuring cyclosporine, its metabolites and derivatives
App 20040198952 - Yatscoff, Randall W. ;   et al.
2004-10-07
Method for producing rapamycin-specific antibodies
App 20040198953 - Yatscoff, Randall W. ;   et al.
2004-10-07
Immunoassay method for measuring a cyclosporine and its metabolites
Grant 6,713,266 - Yatscoff , et al. March 30, 2
2004-03-30
Method for production of antibodies to specific sites of rapamycin
Grant 6,709,873 - Yatscoff , et al. March 23, 2
2004-03-23
Antibodies to specific regions of cyclosporine related compounds
Grant 6,686,454 - Yatscoff , et al. February 3, 2
2004-02-03
Peptide compositions and methods of producing and using same
App 20030228324 - Malcolm, Andrew J. ;   et al.
2003-12-11
Methods and compositions for attenuating antibody-mediated xenograft rejection in human recipients
Grant 6,607,723 - Good , et al. August 19, 2
2003-08-19
Compositions for attenuating antibody- mediated xenograft rejection in human recipients
Grant 5,977,079 - Good , et al. November 2, 1
1999-11-02
Immunogenic oligosaccharide compositions
Grant 5,866,132 - Malcolm February 2, 1
1999-02-02
Methods for attenuating antibody-mediated xenograft rejection in human recipients
Grant 5,767,093 - Good , et al. June 16, 1
1998-06-16
Immunostimulating activity of Streptococcus pneumoniae serotype 8 oligosaccharides
Grant 5,695,768 - Malcolm December 9, 1
1997-12-09
Methods and compositions for attenuating antibody-mediated xenograft rejection in human recipients
Grant 5,651,968 - Good , et al. July 29, 1
1997-07-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed